Breakthroughs in identifying tumor biomarkers in liver, gastric, prostate, lung and other cancers and are accelerating ...
For the first time since last July the FDA's Oncologic Drugs Advisory Committee (ODAC) will meet on Thursday to evaluate two ...
The National Comprehensive Cancer Network® (NCCN®)-an alliance of leading cancer centers-has published a new book explaining ...
UHealth’s Sylvester Comprehensive Cancer Center has adapted radiation therapy into precise individualized treatment. UHealth’s radiation oncologists have spent more than six years adapting radiation ...
Free, comprehensive guidebook shows how prostate cancer screening has largely deemphasized invasive testing in order to avoid unnecessary procedures and treatment while at the same time saving ...
Free, comprehensive guidebook shows how prostate cancer screening has largely deemphasized invasive testing in order to avoid unnecessary procedures and treatment while at the same time saving lives.
Prostate cancer represents one of the most common malignancies in men in developed countries with increasing incidence in recent years due to the ...
Nuclear medicine is being called a new frontier in cancer care, and new research shows potential new uses for it in treating ...
Researchers at the University of British Columbia and BC Cancer have developed a new way to target proteins long considered ...
Jyong Biotech Ltd. (Nasdaq: MENS) (the "Company" or "Jyong Biotech"), a science-driven biotechnology company dedicated to the development and commercialization of innovative plant-derived therapeutics ...
The FDA has released briefing documents detailing its concerns for AstraZeneca’s cancer drugs camizestrant and Truqap ahead ...
Radiopharm Theranostics ADR (NASDAQ:RADX) is among the best Australian stocks to buy in 2026. Radiopharm Theranostics ADR ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results